NCT02669875 - Serelaxin To Lower Portal Pressure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions

Liver CirrhosisHypertension, Portal

Interventions

DRUG

Serelaxin

Serelaxin solution diluted in 5% glucose volume/volume (v/v) solution

DRUG

Placebo

Placebo solution (20mM sodium acetate pH5) diluted in 5% v/v glucose solution

Trial Locations (1)

Liver Unit, Royal Infirmary of Edinburgh, Edinburgh